Home » Topics » Immune, BioWorld Science

Immune, BioWorld Science
RSS

WF-10917: new immunosuppressant from Fujisawa

April 24, 1997

North American Vaccine's acellular pertussis vaccine approved in Sweden

April 23, 1997

Connaught prepares Bordetella vaccine

April 22, 1997

Ergo Science and Massachusetts General Hospital conclude licensing agreement

April 18, 1997

MEDI-507 heads for clinical trials

April 18, 1997

Cytel reports potent immunostimulant useful in vaccine development

April 18, 1997

FDA accepts Wyeth-Ayerst's application seeking approval for rotavirus vaccine

April 17, 1997

Virus Research Institute's Adjumer vaccine delivery system completes phase I

April 17, 1997

U.S. patent allowance related to BioTransplant's XenoMune technology

April 17, 1997

ID's strep vaccine safe and effective in animals

April 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...